Skip to main content
I

IMPULSE (QINGDAO) HEALTH TECH CO., LTD. — Investor Relations & Filings

Ticker · 002899 LEI · 655600Q5CCEIEV1PXE49 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,138 across all filing types
Latest filing 2026-04-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002899

About IMPULSE (QINGDAO) HEALTH TECH CO., LTD.

https://www.impulsefitness.com

Impulse (Qingdao) Health Tech Co., Ltd. specializes in the research, development, and manufacturing of a wide range of fitness equipment. The company provides comprehensive health and wellness solutions, including cardio equipment such as treadmills, ellipticals, and stationary bikes, alongside a diverse portfolio of strength training machines and outdoor fitness installations. Serving commercial fitness centers, hospitality venues, corporate wellness programs, and residential markets, the firm emphasizes ergonomic design and technological integration. Its operations encompass the entire value chain from product conceptualization and engineering to global distribution and after-sales service. By maintaining rigorous quality control and focusing on user-centric innovation, the company has established itself as a significant provider of professional-grade fitness hardware and digital health management systems.

Recent filings

Filing Released Lang Actions
2025年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 0% confidence The document is a standalone table titled “2025年度非经营性资金占用及其他关联资金往来情况汇总表” showing detailed related-party fund occupations and intercompany balances, with signature blocks but no accompanying narrative or formal report context. It is under 5,000 characters and only contains an annex schedule rather than a full annual or interim report, earnings release, audit report, or other defined filing type. As a miscellaneous compliance disclosure that does not neatly match the other specific categories, it falls under a general Regulatory Filing (RNS).
2026-04-28 Chinese
太平洋证券股份有限公司关于青岛英派斯健康科技股份有限公司2022年度向特定对象发行股票项目的保荐总结报告书
Regulatory Filings Classification · 1% confidence The document is a sponsor’s summary report (“保荐总结报告书”) prepared by Pacific Securities for Qingdao Inpasi Health Technology’s 2022 private share issuance, fulfilling CSRC and Shenzhen Stock Exchange regulatory requirements. It is neither an earnings or annual report, nor a proxy, dividend notice, board change, or audit report. It falls under general regulatory/compliance filings that do not fit other specific categories, making it a Regulatory Filing (RNS).
2026-04-28 Chinese
太平洋证券股份有限公司关于青岛英派斯健康科技股份有限公司2025年度保荐工作报告
Regulatory Filings Classification · 1% confidence The document is a “sponsorship work report” prepared by the sponsor (Pacific Securities) for Qingdao Impulse Health Tech Co., Ltd., detailing review of disclosure, governance oversight, on‐site inspections, special opinions, and shareholder commitments for the 2025 period. It is a compliance report filed with the exchange rather than an annual or quarterly financial report, earnings release, proxy statement, dividend notice, or other specific category. It therefore does not match any of the highly specific report types and falls into the fallback category for regulatory/compliance filings (RNS).
2026-04-28 Chinese
青岛英派斯健康科技股份有限公司章程（2026年4月）
Governance Information Classification · 1% confidence The document is the full Articles of Association (公司章程) of Qingdao Impulse Health Tech Co., Ltd., detailing corporate governance rules, internal structures, shareholder meeting procedures, board composition, and related governance practices. This matches the definition of Governance Information (CGR), which covers a report detailing the company’s internal rules, board structure, and governance practices. It is not an announcement or summary but the actual governing charter itself.
2026-04-28 Chinese
2025年度独立董事述职报告-孟凡强
Governance Information Classification · 1% confidence The document is the 2025 annual performance report of an independent director, detailing attendance at board and committee meetings, governance activities, internal control oversight, and compliance with laws and regulations. It is not announcing a board change nor is it an earnings or financial report; rather it focuses on corporate governance practices and the director’s role. This aligns with Governance Information (CGR).
2026-04-28 Chinese
2025年度独立董事述职报告-李强
Regulatory Filings Classification · 1% confidence The document is the independent director’s annual performance report (‘独立董事述职报告’) for Qingdao Impulse Health Science & Technology Co., Ltd. It details the independent director’s duties, meetings attended, compliance with laws, and governance oversight during the 2025 fiscal year. It is not a financial report, earnings release, proxy statement, or share transaction notice, nor is it announcing a report publication. It is a regulatory compliance filing that does not neatly fit another specific category, so it falls under Regulatory Filings (RNS).
2026-04-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.